This is the first update to the original CTS communication distributed on July 6th. As previously communicated, all CTS healthcare partners will remain on the Grifols ZIKV clinical trial until at least the end of October 2018, which coincides with the end of the WNV season.
Check out the Communication page for the complete details on the NAT ZIKV test update or by clicking the link: Communications
In response to the FDA guidance document for Babesia, CTS will implement the licensed Grifols ...
Daylight Saving Time Begins March 10, 2019. As a friendly reminder, airlines often change their rout...
In 2016, the Procleix Panther instrument was introduced by Grifols in support of automated NAT ZIKA ...
After a thorough and comprehensive review of proposals received from suppliers of viral marker testi...
In July, all 5 CTS laboratories will convert from the current Grifols Ultrio Plus NAT triplex assay ...
As a friendly reminder, airlines often change their routine flights and cargo hours for holidays. We...